These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11503631)

  • 1. Pamidronate in incident pain due to bone metastases.
    Mercadante S; Villari P; Ferrera P; Dabbene M
    J Pain Symptom Manage; 2001 Aug; 22(2):630-1. PubMed ID: 11503631
    [No Abstract]   [Full Text] [Related]  

  • 2. [Disodium pamidronate (APD) in the treatment of bone metastases].
    Costa L; Moreira C; da Costa EB
    Acta Med Port; 1993 Feb; 6(2):71-3. PubMed ID: 8488764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials.
    Lipton A; Theriault RL; Hortobagyi GN; Simeone J; Knight RD; Mellars K; Reitsma DJ; Heffernan M; Seaman JJ
    Cancer; 2000 Mar; 88(5):1082-90. PubMed ID: 10699899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of disodium pamidronate in the management of bone pain due to malignancy.
    Groff L; Zecca E; De Conno F; Brunelli C; Boffi R; Panzeri C; Cazzaniga M; Ripamonti C
    Palliat Med; 2001 Jul; 15(4):297-307. PubMed ID: 12054147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pamidronate in patients with painful bone metastases, who failed initial treatment with hormones and/or chemotherapy.
    Cascinu S; Casadei V; Del Ferro E; Alessandroni P; Catalano G
    Support Care Cancer; 1996 Jan; 4(1):31-3. PubMed ID: 8771291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and feasibility evaluation in long term pamidronate treatment of bone metastases].
    Senkus-Konefka E; Krasińska L; Pikiel J; Krasińska W; Nowaczyk M; Jassem J
    Przegl Lek; 2003; 60(7):467-70. PubMed ID: 14750420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating bone metastases: sparing the patient needless pain.
    McBride G
    J Natl Cancer Inst; 1997 Mar; 89(6):418-9. PubMed ID: 9091642
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical value of combined therapy with 188Re-HEDP and pamidronate in breast cancer with bone metastasis].
    Liang JG; Jiang NY; DU JQ; Lu XP; Liu XG; Chen SX
    Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):180-2. PubMed ID: 15946573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of pamidronate in breast cancer with bone metastases: a randomized double-blind placebo controlled multicenter study.
    Hultborn R; Gundersen S; Rydén S; Holmberg E; Carstensen J; Wallgren UB; Kilany S
    Acta Oncol; 1996; 35 Suppl 5():73-4. PubMed ID: 9142971
    [No Abstract]   [Full Text] [Related]  

  • 10. Pamidronate treatment in patients with malignant osteolytic bone disease and pain: a prospective randomized double-blind trial.
    Koeberle D; Bacchus L; Thuerlimann B; Senn HJ
    Support Care Cancer; 1999 Jan; 7(1):21-7. PubMed ID: 9926970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A remarkable improvement of clinical manifestations in a breast cancer patient with widespread bone metastases after administration of pamidronate.
    Kage K; Nagahama T; Sekine I; Maruyama M; Ogata E
    Intern Med; 1997 Dec; 36(12):926-30. PubMed ID: 9475253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analgesic effect of Pamidronate on bone pain in patient with hypertrophic pulmonary osteoarthropathy].
    Bileckot R; Touazi S; Auvinet B; Le Lain JC
    Rev Pneumol Clin; 2001 Jun; 57(3):233-4. PubMed ID: 11416808
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group.
    Hortobagyi GN; Theriault RL; Porter L; Blayney D; Lipton A; Sinoff C; Wheeler H; Simeone JF; Seaman J; Knight RD
    N Engl J Med; 1996 Dec; 335(24):1785-91. PubMed ID: 8965890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of onset of analgesia using intravenous pamidronate in metastatic bone pain.
    Petcu EB; Schug SA; Smith H
    J Pain Symptom Manage; 2002 Sep; 24(3):281-4. PubMed ID: 12458105
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pamidronate in the treatment of bone metastases from breast cancer].
    Nagykálnai T; Landherr L; Zatkóné GP; Gyuricska A
    Magy Onkol; 2002; 46(3):225-33. PubMed ID: 12368918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonate therapy in metastatic breast cancer.
    Blomqvist C; Elomaa I
    Acta Oncol; 1996; 35 Suppl 5():81-3. PubMed ID: 9142974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pamidronate infusions as single-agent therapy for bone metastases: a phase II trial in patients with breast cancer.
    Tyrrell CT; Bruning PF; May-Levin F; Rose C; Mauriac L; Soukop M; Ford JM
    Eur J Cancer; 1995 Nov; 31A(12):1976-80. PubMed ID: 8562151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Two bedridden patients with bone metastases from breast cancer effectively treated with pamidronate therapy].
    Kokufu I; Taniguchi H; Kim YH; Fukuda K; Yamamoto M; Yano T; Yamada K; Kitano H
    Gan To Kagaku Ryoho; 2000 Oct; 27(11):1751-4. PubMed ID: 11057329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed progression of bone metastases with pamidronate therapy in breast cancer patients: a randomized, multicenter phase III trial.
    Conte PF; Giannessi PG; Latreille J; Mauriac L; Koliren L; Calabresi F; Ford JM
    Ann Oncol; 1994; 5 Suppl 7():S41-4. PubMed ID: 7873461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The evaluation of pamidronate therapy for bone metastases from breast cancer].
    Nomizu T; Yabuta T; Katagata N; Watanabe F; Yamaki Y; Nihei M; Tsuchiya A; Takenoshita S; Abe R
    Gan To Kagaku Ryoho; 2000 Nov; 27(13):2097-103. PubMed ID: 11103241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.